Home World News Adding Retifanlimab To Chemotherapy Provides OS Benefit over Chemotherapy In First-Line Treatment...

Adding Retifanlimab To Chemotherapy Provides OS Benefit over Chemotherapy In First-Line Treatment of Patients with Advanced Squamous Anal Cancer

May 18, 2026

234

Findings from the final overall survival analysis in the POD1UM-303/InterAACT-2 study